1-Methyl-1H-imidazol-3-ium chloride

Catalog No.: 
ACLIRC147
CAS No.: 
35487-17-3
Molecular Formula: 
C4H7ClN2
Molecular Weight: 
118.57
1-Methyl-1H-imidazol-3-ium chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%
500g97%
1000g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methyl-1H-imidazol-3-ium chloride
IUPAC Name1-methyl-1H-imidazol-3-ium chloride
MDL No.MFCD06798176
Molecular FormulaC4H7ClN2
Molecular Weight118.57
SMILESCN1C=C[NH+]=C1.[Cl-]
InChI KeySTCBHSHARMAIOM-UHFFFAOYSA-N
Synonymn-methylimidazole hydrochloride | n-methylimidazolium chloride | 1-Methylimidazolium chloride, 95% | 1-methylimidazole;hydrochloride | CS-0188308 | 1-Methylimidazolium chloride | AKOS015912541 | DTXSID60479995 | 1-Methylimidazolium Chloride Quality | AS-7
CAS No.35487-17-3
PubChem CID12196634

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLIRC147 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8In Stock
  4. Then
  5. ACLIRC147 route product structure diagram
    ACLIRC14735487-17-3In Stock
Inquiry

2. ACLIRC147 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLIRC147 route product structure diagram
    ACLIRC14735487-17-3In Stock
Inquiry

3. ACLIRC147 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLIRC147 route product structure diagram
    ACLIRC14735487-17-3In Stock
Inquiry

Comments (0)